Stocks

Headlines

Insider Buying Signals Opportunity for Synaptics and Oncocyte

Insider Buying Trends: Synaptics and Oncocyte. Bargain hunters are taking note of significant insider purchases at Synaptics and Oncocyte, hinting at potential growth and investor confidence.

Date: 
AI Rating:   7

Insider Buying Activity: The report highlights significant insider purchasing activities in two companies: Synaptics and Oncocyte. When insiders buy shares, it typically reflects their positive sentiment regarding the company's future performance, which can be a positive signal for potential investors.

At Synaptics, CFO Ken Rizvi made a notable purchase of 3,600 shares at $69.15 each, amounting to $248,940. The stock has shown a positive movement of approximately 1.8%, which could suggest growing confidence in the company's profitability or market position.

Furthermore, in Oncocyte, CFO Andrea S. James purchased $200,000 worth of shares, buying 97,561 shares at a price of $2.05 each. This investment followed two prior purchases totaling $145,800 at an average share price of $2.72. After the recent purchase, the stock price rose about 5.4%, and James appears to be experiencing gains of about 26.8% relative to the current trading high of $2.60. This indicates not only insider confidence but also positive market sentiment surrounding Oncocyte.

Stocks:  SYNA OCX